Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
|
CN |
|
M
|
Mercor SA
WSE:MCR
|
PL |
|
Chia Hsin Cement Corp
TWSE:1103
|
TW |
|
Sixth Street Specialty Lending Inc
NYSE:TSLX
|
US |
|
METISA Metalurgica Timboense SA
BOVESPA:MTSA4
|
BR |
|
Reliance Communications Ltd
NSE:RCOM
|
IN |
|
P
|
Pecca Group Bhd
KLSE:PECCA
|
MY |
|
Labcorp Holdings Inc
BMV:LH
|
US |
|
Ribomic Inc
TSE:4591
|
JP |
|
Silvercrest Metals Inc
TSX:SIL
|
CA |
|
Heritage Financial Corp
NASDAQ:HFWA
|
US |
|
M
|
Memscap SA
PAR:MEMS
|
FR |
|
G
|
Guangzhou Lingwe Technology Co Ltd
SZSE:301373
|
CN |
|
BECE Legend Group Co Ltd
SZSE:000803
|
CN |
|
H
|
Hipay Group SA
LSE:0RA7
|
FR |
Bankruptcy Probability
Qianjiang Yongan Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Qianjiang Yongan Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
|
3.8B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Qianjiang Yongan Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Qianjiang Yongan Pharmaceutical Co Ltd has total debt of 45.2m CNY. This includes both short-term (45.2m CNY) and long-term (0 CNY) debt.
You can find a full breakdown on its Balance Sheet.
